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Abstract
Words = 248/250
Purpose Few studies have explored measures of function across a range of health outcomes in a general
working population. Using four upper extremity (UE) case definitions from the scientific literature, we
described the performance of functional measures of work, activities of daily living, and overall health.
Methods A sample of 573 workers completed several functional measures: modified recall versions of
the QuickDASH, Levine Functional Status Scale (FSS), DASH Work module (DASH-W), and standard SF-8
physical component score. We determined case status based on four UE case definitions: 1) UE
symptoms, 2) UE musculoskeletal disorders (MSD), 3) carpal tunnel syndrome (CTS), and 4) work
limitations due to UE symptoms. We calculated effect sizes for each case definition to show the
magnitude of the differences that were detected between cases and non-cases for each case definition
on each functional measure. Sensitivity and specificity analyses showed how well each measure
identified functional impairments across the UE case definitions.
Results All measures discriminated between cases and non-cases for each case definition with the
largest effect sizes for CTS and work limitations, particularly for the modified FSS and DASH-W measures.
Specificity was high and sensitivity was low for outcomes of UE symptoms and UE MSD in all measures.
Sensitivity was high for CTS and work limitations.
Conclusions Functional measures developed specifically for use in clinical, treatment-seeking
populations may identify mild levels of impairment in relatively healthy, active working populations, but
measures performed better among workers with CTS or those reporting limitations at work.

Keywords (max of 5) Case definitions, Health outcomes, functional measures, occupational injuries,
work
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Introduction
Assessment of functional outcomes related to health is necessary for both researchers and
clinicians as diagnosis alone is a poor predictor of clinical and functional outcomes [1]. Measurement of
functional outcomes is becoming increasingly important for assessing improvement in health-related
quality of life of patients or populations, justifying and obtaining reimbursement for healthcare services,
providing an economic interpretation of the burden of chronic diseases, and demonstrating efficacy of
interventions in clinical trials [2-5]. Many measures of the impact of musculoskeletal disorders (MSDs)
and chronic health conditions on the performance of functional activities have been developed over the
last two decades [6-8]. Although some measures have undergone extensive psychometric testing to
determine their reliability and validity, few studies are available to guide researchers and clinicians
about which measure(s) are best suited for use in a given setting, population, or stage of disease
severity [3, 9, 10].
Some measures of upper extremity function that have been used in recent musculoskeletal
research studies, such as the Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) [11], the
Work module of the DASH (DASH-W), and the Functional Status Scale (FSS) from the Boston Carpal
Tunnel Questionnaire [12], were designed and validated for use in clinical populations. The QuickDASH is
a region-specific measure that was designed to assess functional outcomes relevant to a range of
conditions affecting the upper extremity (UE) [13]. The Work module of the DASH (DASH-W) is designed
to assess difficulties with work performance due to UE disorders. The QuickDASH and DASH-W have
been tested and widely used in orthopedic and rehabilitation settings among patients for many different
UE musculoskeletal disorders (MSDs) [3, 14-18]. However, both workplace-based studies and
comparative studies against other functional measures have been more limited, especially for the DASHW [19-24]. The FSS was designed for use in clinical patients seeking treatment for symptoms of carpal
tunnel syndrome (CTS), and has primarily been tested in patients undergoing surgical interventions for
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CTS [12, 25]. The Short-form 8 health survey (SF-8) is a generic health status measure that assesses
multiple domains of health and well-being, and was developed for assessment of health-related quality
of life in national health surveys [26]. The SF-8 has been tested in both general population samples and
specific patient samples [26, 27].
Clinical populations are comprised of people who are treatment-seeking and likely represent a
more symptomatic and severe range of disease than found in general or working populations. It is
unclear how well measures designed for clinical populations perform in relatively healthy active working
populations [19, 20] and whether the response scales are able to capture functional limitations
corresponding to early stage disease [28]. Using functional measures in working populations may
identify early stages of disease, allowing for interventions to improve work ability, prevent disability, and
promote return to work following injury [29, 19-21]. Epidemiological studies have used a range of case
definitions associated with MSD outcomes including symptoms alone, symptoms plus physical signs, or
various functional outcomes [30-32]. Simultaneous comparison of the performance of multiple health
measures against various UE MSD outcomes would inform research and clinical practice regarding which
measure(s) may be used to identify mild levels of impairment in relatively healthy, active working
populations.
The purpose of this study was to evaluate the performance of several standardized measures of
functional work performance, activities of daily living, and overall health in relation to four upper
extremity (UE) case definitions: 1) UE symptoms, 2) UE musculoskeletal disorders (MSD), 3) carpal tunnel
syndrome (CTS), and 4) work limitations due to UE symptoms.
Materials and Methods
Participants
Study participants were subjects in the prospective Predictors of Carpal Tunnel Syndrome
(PrediCTS) study. Subjects were enrolled in the PrediCTS study (2004-2006) as full-time, newly hired
4

workers in construction, service, and clerical jobs. Detailed descriptions of subject recruitment for the
PrediCTS study may be found in several prior publications [33, 34, 32, 35]. The present analysis included
subjects who completed a follow-up visit between March 2012 and August 2013, consisting of a selfreported questionnaire, physical examination of the upper extremity, and nerve conduction studies of
the hands. This study was approved by the Institutional Review Board of the Washington University in
St. Louis School of Medicine. All subjects provided written informed consent and were compensated.
Data Collection
Subjects completed self-reported questionnaires collecting information about demographics,
employment history, physical and psychosocial job exposures, UE symptoms, and functional and work
limitations related to UE symptoms. Trained research technicians performed a standardized physical
examination for clinical signs of UE MSDs, including tenderness to palpation and standard provocative
maneuvers. Research technicians also performed standardized bilateral nerve conduction testing of the
median and ulnar nerves at the wrist to determine the presence of abnormal median neuropathy
consistent with carpal tunnel syndrome. Specific methods are described in previous publications [36-38].
Functional Measures
As described below, standardized measures assessed three general domains of health and
functioning: activities of daily living (ADL), work performance, and overall health. Assessments were
administered to all participants, although the 1-year recall modified QuickDASH was only administered
to subjects with UE symptoms.
1-year recall modified QuickDASH
The QuickDASH is an 11-item, shortened version of the Disabilities of the Arm, Shoulder, and
Hand (DASH) outcome measure. The QuickDASH is designed to measure physical functioning in people
with UE disorders. Respondents are asked to rate their ability to perform various activities of daily living
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and the severity of their symptoms, on a scale from “1” to “5.” A minimum of 10 of the 11 QuickDASH
items must be completed in order for a score to be calculated. Completed responses are summed and
averaged. The average value is transformed to a 0 to 100 scale by subtracting one and multiplying by 25.
Higher scores indicate greater disability [15]. The QuickDASH has been shown to be reliable and valid in
various clinical populations [15, 39, 40]. The recall period for the QuickDASH was modified from the
original timeframe of “during the past week” to “when your symptoms were the worst in the past year”
to parallel the reference time frame used for other measures in the PrediCTS study. Due to the modified
recall period, we refer to the QuickDASH in this study as the 1-year recall modified QuickDASH.
Modified Functional Status Scale
The Functional Status Scale (FSS) from the Boston Carpal Tunnel Questionnaire is an 8-item
questionnaire originally developed by Levine et al. [12] to assess functional abilities in patients with CTS.
The FSS has shown good reproducibility, internal consistency and responsiveness to change in surgical
patients [12]. Each item of the FSS is rated on a scale from “1” “no difficulty” to “5” “unable.” The
overall score for the FSS is calculated as the mean of the completed items, and ranges from 1 to 5 [12].
Higher scores indicate greater disability. Similar to the QuickDASH, the recall period for the FSS was
modified from the original two-week recall period to one year, and is described as the modified FSS in
this study.
1-year recall modified DASH Work Module
The DASH Work module (DASH-W) is a 4-item scale assessing the impact of UE conditions on
physical work ability. Workers are asked to rate their difficulty in performing work activities on a scale
from “1” “no difficulty” to “5” “unable.” All 4 items must be completed in order to calculate a score. The
DASH-W is scored by summing all four responses and dividing by 4 to get an average. Then, 1 is
subtracted and the value is multiplied by 25 to get a final score ranging from 0 to 100. Higher scores
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indicate greater disability [41, 42]. We also used a one-year recall period for the DASH-W, in order to be
consistent with the other outcome measures, which is referred to as the 1-year recall modified DASH-W.
Short form-8 (SF-8) Health Survey: Physical Component Score
The SF-8 Health Survey is an 8-item scale designed to assess self-perception of overall health
and ability to perform daily activities. The SF-8 has shown acceptable reliability compared with the
longer, more widely tested SF-36 health survey [26]. Items are scored on “1” to “5” scales with various
verbal anchors. The SF-8 was scored to yield the physical component score (PCS-8) according to the
developers’ recommendations [26]. If any items were missing, a score was not calculated. Higher scores
on the PCS-8 indicate better health. In contrast to the other measures in this study, the PCS-8 used a 4week recall period.
Case definitions
Subjects were determined to meet or not meet each of the four UE case definitions described
below for 1) UE symptoms, 2) UE MSD, 3) CTS, and 4) work limitations due to UE symptoms.
UE Symptoms
Subjects reported symptoms in three regions of the UE that would commonly be used in
epidemiological case definitions for UE MSDs. “In the past YEAR, have you had any RECURRING
(repeated) symptoms in your (Shoulders/upper arms, Elbow/forearms, or Hands/Wrists/fingers) more
than 3 times or lasting more than ONE week?” [43]
UE MSD
Among subjects reporting UE symptoms (#1 above), those who also had corresponding positive
physical sign for a MSD of the shoulder, elbow, or wrist, met our epidemiological case definition of an
UE MSD[31]. The case definitions considered for this study were rotator cuff tendonitis, biceps
tendonitis, lateral or medial epicondylitis, radial tunnel syndrome, cubital tunnel syndrome,
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deQuervain’s tenosynovitis, wrist flexor or extensor tendonitis, or carpal tunnel syndrome (defined in
the following paragraph) [31].
Carpal tunnel syndrome (CTS)
CTS cases were contained within the UE MSD category, but we also evaluated CTS cases
separately because the FSS (from the Boston CTS Questionnaire) was designed to specifically evaluate
function of patients with CTS, CTS is one of the most expensive work-related diagnoses, and we had a
small but reasonable number of cases to allow this study. Subjects with typical median nerve symptoms
and abnormal median neuropathy of the same hand met our case definition for CTS [44]. Median nerve
symptoms included numbness, tingling, burning, or pain in at least one of the thumb, index, or middle
fingers, reported on a hand diagram [45, 46]. Criteria for abnormal median neuropathy was defined as
median distal motor latency greater than 4.5 milliseconds (ms), median distal sensory latency greater
than 3.5 ms, or median-ulnar sensory latency difference greater than 0.5 ms [47].
Work limitations due to UE symptoms
Subjects who reported UE symptoms were asked to complete six additional items from the
University of Michigan Upper Extremity Questionnaire (UEQ) [48, 49], to describe work limitations that
resulted from having UE symptoms. We created a composite work limitations outcome from these
questionnaire items which included self-reported limitations in work ability or productivity, or missing
days from work, having job restrictions, or changing jobs or companies due to one’s symptoms. We have
used a similar case definition for work limitations in our prior studies [32, 50].

Statistical Analysis
Descriptive statistics were calculated for the study population and the frequencies of each case
definition. We ran correlations between the functional measures using Spearman rank correlations. We
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considered correlation coefficients of 0.7 to 0.9 to be strong, 0.4 to 0.7 moderate, and less than 0.4
weak [51]. We expected moderate correlations at best between the measures based on differences in
the constructs each measure was designed to assess, as well as the strength of associations that have
been shown in prior studies [19, 23, 3]. Because lower scores on the SF-8 indicate worse health, whereas
higher scores on all of the other measures indicate greater disability, negative correlations were
expected between the SF-8 (PCS-8) and the other measures.
We determined if there were statistically significant differences in mean scores between cases
and non-cases for each cases definition on each of the measures using Student’s t-tests. We also
reported the effect sizes (Cohen’s D) to show the magnitude of the differences that were detected
between cases and non-cases for each case definition on each functional measure.
Finally, we compared the sensitivity and specificity of each measure across each of the case
definitions for UE symptoms, UE MSD, CTS, and work limitations, to evaluate how well each measure
identified functional impairments across a range of UE case definitions. We selected a cut-point for each
measure using normative population scores from the scientific literature. We selected a cut-point of
8.81 points for the 1-year recall modified DASH-W from the U.S. normative population mean value for
the standard 1-week recall version of the measure [52]. We selected the U.S. population mean value of
50 as the cut-point for the SF-8 physical component score [26]. As the FSS was designed for a clinical
population, there has been no population mean score determined. Therefore, subjects whose score was
more than 0.5 standard deviations (SD) above the mean were considered as having functional
limitations. Our PrediCTS cohort at 6 months had an average FSS score of 1.14 (SD 0.38)[32]. We used a
score difference of (0.5(SD) + Mean), or 1.3 points as a cut-point for the FSS. This value shows slightly
less impairment than the post-surgical average score for CTS patients as previously reported by Levine
and colleagues (FSS score = 1.9) [12]. Sensitivity and specificity could not be calculated for the
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QuickDASH since it was only completed by symptomatic workers. Analyses were conducted using R
version 3.1 and SAS Version 9.3 (Statistical Analysis System Institute, Cary, NC).

Results
From the original PrediCTS cohort, 573 subjects were included in the present analyses. The
majority of subjects were male (62%), with a mean age of 38.4 years (SD 10.8), and the largest
proportion was employed in construction trades (31%) (see Table 1). Among the full cohort, 40% of
subjects had UE symptoms and 25% of the cohort had symptoms and signs, meeting an UE MSD case
definition. The prevalence of work limitations due to UE symptoms and CTS were substantially lower, 9%
and 4%, respectively. Compared with a clinical population in which 100% of subjects would be
symptomatic and would be seeking treatment, there was a relatively low prevalence of disease in this
actively working population, with only 12% of the overall cohort reporting having sought treatment from
a medical professional in the past year.
Distributions of functional outcome scores
Descriptive statistics including distributions of scores, means, and median scores for each
measure are shown in Table 2. Subject responses represented the full range of possible scores on each
measure; however, the relatively low median scores across all measures suggested a relatively moderate
MSD disease spectrum in this cohort.
Correlations between measures
Correlations among the measures ranged from poor to strong (-0.34 to 0.85) (Table 3). The 1year recall modified QuickDASH was strongly correlated to the modified FSS (r=0.85) and the 1-year
recall modified DASH-W (r=0.76). Correlations of the SF-8 PCS-8 with other measures were weak to
moderate (-0.34—-0.43).
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Performance of the measures against 4 UE case definitions
Results of t-tests showed statistically significant differences on all functional measures between
cases and non-cases for UE symptoms, UE MSD, CTS, and work limitations (Table 4). Cases reported
higher levels of ADL limitations, work disability, and worse overall health than non-cases for each
outcome. Effect sizes showed larger differences for all measures between cases and non-cases of CTS
and work limitations. For CTS, the largest differences between cases and non-cases were shown with the
modified FSS; for work limitations the largest differences between cases and non-cases were seen on
the 1-year recall modified DASH-W.
Applying one cut-point for each measure across all case definitions allowed us to compare the
sensitivity and specificity of each measure for the four UE case definitions (Table 5). In general,
sensitivity of all measures was low and specificity was high in relation to UE symptoms and UE MSD.
Sensitivity was higher for classifying workers with CTS and work limitations for all measures. The 1-year
recall modified DASH-W showed the highest sensitivity in relation to the work limitations case definition.
Discussion
This study examined the utility of several measures of work ability, functional limitations, and
overall health for a range of UE health outcomes in a working population. This study helps to fill
important gaps in the literature as few previous studies have directly compared these functional
measures for various musculoskeletal case definitions or in an actively working population. Workers
with UE symptoms, UE MSD, CTS, and work limitations due to UE symptoms reported worse ADL
function, more limited work performance, and worse overall health than non-cases. Measures generally
showed higher sensitivity and lower specificity with increasing levels of impairment, suggesting that
measures performed better with more defined states of disease in this generally healthy population.
Measures designed to assess similar constructs of health and function were moderately to
strongly correlated with one another, such as the modified versions of the QuickDASH and FSS which
11

both address functional performance of daily activities. The strong correlation observed between the 1year recall modified QuickDASH and DASH-W (r=0.76) is consistent with the findings of Fan et al.,
comparing the standard QuickDASH and DASH Work module (r=0.63) in active workers with UE
symptoms and clinical cases for UE MSD [19] and those of House et al. comparing the full DASH and
DASH-W in workers with hand-arm vibration syndrome (r=0.64) [22]. In another study that compared
the full Boston Carpal Tunnel Questionnaire (BCTQ), from which the FSS is taken, stronger correlations
were observed between the BCTQ and the full DASH, than with measures of overall health such as the
SF-36, from which the SF-8 was developed [25]. Our findings are consistent with those of Leite et al.,
with strong correlations observed between the modified FSS and 1-year recall modified QuickDASH, but
weaker correlations with the SF-8 physical component score [25].
Many previous studies have shown that clinical patients with UE MSD report problems with
functional performance [11, 14, 53, 54]. Studies in non-clinical populations are limited, but the growing
body of literature suggests that active workers with UE symptoms also experience difficulties in ADL and
work performance [19-21, 55, 23]. Even in this relatively young, healthy working population in which
few workers sought medical treatment (12%), cases for all outcomes reported more difficulty
performing ADL and work activities. In addition, workers with UE conditions also perceived themselves
to have lower overall health, as measured by the SF-8. These findings provide support for the ability of
all of the measures to discriminate statistically significant differences between cases and non-cases
along a range of severity for UE conditions in workers.
The sensitivity and specificity of measures can vary among patients in different settings or
different stages of disease severity. Our findings showed higher sensitivity of measures with case
definitions that suggest greater levels of impairment, whereas the specificity was lower. These findings
suggest that functional measures showed weaker ability to discriminate between workers at lower
levels of disease severity. Measures that are more closely related to the outcome are more likely to be
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sensitive to discriminating cases from non-cases [9]. The DASH-W is an UE region-specific measure which
was developed for clinical populations, and has performed well in relation to a variety of UE disorders
[56]. In our study, the 1-year recall modified DASH-W showed the highest sensitivity in relation to our
work limitations outcome. The FSS is a condition-specific measure designed for use with patients seeking
treatment for CTS, and showed its highest sensitivity for CTS versus the other UE case definitions. Even a
measure of overall physical health, the SF-8 physical scale, showed differences between cases/non-cases
for each UE outcome in this study. Selection of appropriate measures should be guided by the outcome
of interest and which measures relate best to the outcome.
As described in a review of functional measures for workers with UE MSDs, few measures have
been developed specifically for identifying mild levels of impairment in relatively healthy working
populations [28]. Salerno et al. recommended three measures that were developed for research
application as the most relevant measures for mild UE conditions: the Nordic Musculoskeletal
Questionnaire (NMQ), the Neck and Upper Limb Instrument (NULI), and the UEQ which included items
from which our work limitations outcome was derived [28]. Although several measures including the
DASH and FSS have been used in previous studies of workers, few studies have tested their performance
among workers with mild to moderate UE conditions [28, 19-21]. Our findings provide new evidence
supporting the use of these measures in a mildly impaired population, even though they were primarily
designed for clinical application.
One limitation of our study was in the design of our questionnaire. The 1-year recall modified
QuickDASH was only completed by subjects with symptoms, thus we could not calculate t-tests between
scores for cases and non-cases or sensitivity and specificity. All measures used a 1-year recall period
except for the SF-8 which used the standard 4-week recall period. This difference in recall periods may
have contributed to the weak correlations found between the SF-8 PCS-8 and other measures.
Modifying the recall periods from those suggested by developers of the QuickDASH, DASH-W, and FSS
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may limit comparisons of our data with previous studies or with normative data. According to a recent
study by Norquist et al., recall periods for patient-reported outcome measures should depend upon the
attributes of the disease or phenomenon of interest [57]. Our study was longitudinal with the frequency
of follow-up of approximately one year. Workers reported on symptoms that ranged from mild to
severe and were episodic in nature. The recall periods chosen for the measures included in our
questionnaires were selected to correspond with the one-year recall period for the Nordic-style
symptom questions. Some authors also caution that lengthening the recall period of measures may
cause subjects to underreport functional limitations due to symptoms that occurred as much as 1 year
prior [58, 59]. Stepan et al., however, showed that patients with orthopedic hand and elbow injuries
were able to accurately recall their baseline functional status on the QuickDASH up to 2 years following
an initial office visit [54].
An important strength of our study was the simultaneous comparison of multiple health
measures across a range of UE disease severity. We assessed how well various measures were
associated with common MSDs and functional work outcomes. Measures are often chosen without
regard to how well they relate to the research question or outcome being studied. Previous studies of
functional and disability measures have explored reliability and validity, but seldom provide guidance to
researchers and clinicians as to which measure may be most applicable in a given setting or population.
Our study population was an active working population rather than a clinical population. Most of the
measures in this study were either tested in or designed primarily for use in clinical populations and few
studies have examined their utility in working populations with a wider range of disease severity.
Although all of the functional and work limitation measures were able to detect differences between the
case and non-case groups of active workers across a range of UE health conditions, our results suggest
that measures most closely related to the outcome of interest may perform better. The 1-year recall
modified DASH-W showed the highest sensitivity and largest effect size for distinguishing workers with
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and without work limitations, and the FSS showed better performance for the CTS case definition versus
the other UE case definitions. Additional longitudinal studies in active working populations are needed.
Future work will look at the responsiveness of the measures to detect clinically meaningful change over
time and the ability of different measures to predict future disability among active workers. Assessment
of functional outcomes is important in both research and clinical practice, however, the performance of
measures in the population and setting of interest should be considered.
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Table 1. Demographic characteristics of the study population and frequencies of the
outcomes (n=573)
Characteristic
Age
Body mass index (kg/m2)

Mean (SD)
38.4 (10.8)
29.9 (7.0)
n (%)

Gender
Male
Female
Job Category
Construction
Service
Office/Clerical
Technical
Unemployed
Sought treatment for upper extremity symptoms from a
medical professional, in the past year
Outcomes
Upper extremity symptoms
General work limitations due to upper extremity
symptoms
Upper extremity musculoskeletal disorder
Carpal tunnel syndrome
Abbreviations: SD, standard deviation.

353 (62)
220 (38)
180 (31)
160 (28)
94 (17)
54 (9)
85 (15)
70 (12)
n (%)
228 (40)
50 (9)
145 (25)
24 (4)
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Table 2. Distributions of scores of each functional measure in the study population (n=573)
Measures
Number of
Mean (SD) Median (IQR)
Range of
useable
subject scores
observations
QuickDASH (1-year recall modified)a,b
226
27.3 (21.5)
21.6 (27.3)
0-95.5
Functional Status Scale (modified recall)b

573

1.3 (0.7)

1 (0.4)

1-5

DASH-W (1-year recall modified)b

553

9.1 (19.6)

0 (6.3)

0-100

c

SF-8 physical component score
573
52.3 (7.4)
54.2 (7.3)
13.6-66.0
Abbreviations: IQR, interquartile range; SD, standard deviation; DASH, Disabilities of the Arm, Shoulder,
and Hand; DASH-W, DASH Work module; SF, short form.
a
The 1-year recall modified QuickDASH was completed only by subjects who reported upper extremity
symptoms.
b
Higher scores indicate greater disability.
c
Lower scores indicate worse health.
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Table 3. Spearman correlation coefficients between the functional measures (n=573)
Functional
SF-8 Physical
QuickDASHa
DASH-Wa
a
Component
(1-year recall Status Scale (1-year recall
Scoreb
modified)
(modified
modified)
(n=226)
recall)
(n=553)
(n=573)
(n=573)
QuickDASH (1-year recall modified)
1
p
combined n
Functional Status Scale (modified recall)
0.85
1
p
<.0001
combined n
226
DASH-W (1-year recall modified)
0.76
0.63
1
p
<.0001
<.0001
combined n
215
553
SF-8 Physical component score
-0.43
-0.35
-0.34
1
p
<.0001
<.0001
<.0001
combined n
226
573
553

Abbreviations: DASH, Disabilities of the Arm, Shoulder, and Hand; DASH-W, DASH Work module;
SF, short form.
a
Higher scores indicate greater disability.
b
Lower scores indicate worse health.
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Table 4. Differences between cases and non-cases of upper extremity symptoms, upper extremity musculoskeletal disorders, carpal tunnel syndrome, and work limitations due to upper extremity symptoms, on
the functional measures (n=573)
Upper extremity symptoms

Measures

Case
n = 228

Non-case
n = 345

QuickDASH (1-year recall modified)c (n=226)
n
226
0
Mean (SD)
27.3 (21.5)
n/a (n/a)
FSS (modified recall) (n=573)
n
228
Mean (SD)
1.8 (0.9)

345
1.1 (0.2)

DASH-W (1-year recall modified) (n=553)
n
217
Mean (SD)
21.2 (26.2)

336
1.3 (6.0)

SF-8 Physical component score d (n=573)
n
228
Mean (SD)
49.5 (8.3)

345
54.2 (6.0)

Student's Ttest
Effect size b
(p-Value)

n/a

1.045
(<0.0001)

1.014
(<0.0001)

-0.639
(<0.0001)

Upper extremity musculoskeletal
disorder
Case
Non-case
Student's Tn = 145
n = 428
test
Effect size b
(p-Value)
143
30.0 (21.8)

83
22.6 (20.4)

145
1.8 (0.9)

428
1.2 (0.5)

136
23.3 (26.7)

417
4.5 (13.8)

145
47.8 (9.0)

428
53.9 (6.0)

0.344
(0.0111)

0.956
(<0.0001)

0.959
(<0.0001)

-0.819
(<0.0001)

Carpal tunnel syndrome a
Case
n = 24

Non-case
n = 548

24
48.0 (25.1)

201
24.9 (19.8)

24
2.6 (1.1)

548
1.3 (0.6)

22
37.2 (27.2)

530
8.0 (18.4)

24
43.9 (10.1)

548
52.7 (7.0)

Student's Ttest
Effect size b
(p-Value)

1.075
(0.0002)

1.913
(<0.0001)

1.492
(<0.0001)

-1.187
(0.0003)

Work limitations due to upper extremity
symptoms
Case
Non-case
Student's Tn = 50
n = 523
test
Effect size b
(p-Value)
48
49.8 (24.2)

178
21.2 (16.1)

50
2.4 (1.2)

523
1.3 (0.5)

48
52.1 (31.0)

505
5.0 (11.8)

50
46.6 (11.2)

523
52.9 (6.7)

1.329
(<0.0001)

1.729
(<0.0001)

Abbreviations: DASH, Disabilities of the Arm, Shoulder, and Hand; DASH-W, DASH Work module; FSS, Functional Status Scale; SF, short form; SD, standard deviation.
a Case status could not be determined for 1 subject due to missing nerve conduction values.
b
Cohen's D
c For 1-year recall modified QuickDASH Score, a t- test could not be performed for the upper extremity symptoms case definition because subjects who had no symptoms did not complete the modified QuickDASH.
d
Higher scores on the SF-8 indicate better health.
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2.399
(<0.0001)

-0.85 (0.0003)

Table 5. Sensitivity and specificity of each functional measure for four upper extremity case definitions based on a
common cut-point for each measure (n=573)
Upper extremity
symptoms (n=228)

Measures
FSS (modified recall)
DASH-W (1-year
recall modified)

Common
cutpointa
1.3

Sens.

Spec.

Upper extremity
musculoskeletal
disorder (n=145)
Sens.
Spec.

Carpal tunnel
syndrome
(n=24)
Sens.
Spec.

Work limitations due
to upper extremity
symptoms (n=50)
Sens.
Spec.

56.1

93.0

60.0

84.8

79.2

75.9

76.0

78.2

8.81

53.0

95.2

55.1

86.6

81.8

78.7

89.6

82.6

SF-8 Physical
50
39.9
85.2
49.7
83.6
66.7
77.0
52.0
77.8
component score
Abbreviations: Sens, sensitivity; Spec, specificity; FSS, Functional Status Scale; DASH-W, Disabilities of the Arm, Shoulder, and Hand
Work module; SF, short form.
a
Common cut-points were applied to each measure across all of the case definitions, in order to compare sensitivity and specificity
of each measure for each case definition. Common cut-point for the modified Functional Status Scale was derived using data from
the same cohort at a different study time-point using the formula: (0.5(SD) + Mean). Common cut-points for the 1-year recall
modified DASH-W and SF-8 were selected from the medical literature.
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